The substitution of gallic acid at the 3 position of (-)-epigallocatechin-3
-O-gallate (EGCG) increased the inhibition against topolsomerase I from cal
f thymus gland and topoisomerase H from human placenta, and the substitutio
n of a hydroxyl group at the 3 ' position increased the inhibition against
the topoisomerase I. These results suggested that the 3 and 3 ' positions o
f the EGCG molecule play important roles in the process of inhibition of to
poisomerases I and II. EGCG showed strong inhibition against topoisomerases
I from wheat germ, calf thymus gland and Vero cells, and showed weak or no
inhibition against topoisomerases I from carcinoma cells such as A549, HeL
a and COLO 201 cells. EGCG differentially inhibited the topoisomerases I fr
om different sources.